{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T14:38:24Z","timestamp":1780583904919,"version":"3.54.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.jbspin.2011.04.013","type":"journal-article","created":{"date-parts":[[2011,6,27]],"date-time":"2011-06-27T22:16:57Z","timestamp":1309213017000},"page":"550-554","source":"Crossref","is-referenced-by-count":23,"title":["Interleukin-33: A novel player in osteonecrosis of the femoral head?"],"prefix":"10.1016","volume":"78","author":[{"given":"Soraya","family":"Saidi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Magne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2011.04.013_bib0005","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejrad.2007.03.019","article-title":"Osteonecrosis of the femoral head: etiology, imaging and treatment","volume":"63","author":"Malizos","year":"2007","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.jbspin.2011.04.013_bib0010","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jbspin.2006.01.025","article-title":"Pathophysiology and natural history of avascular necrosis of bone","volume":"73","author":"Lafforgue","year":"2006","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2011.04.013_bib0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1302\/0301-620X.67B1.3155745","article-title":"Idiopathic bone necrosis of the femoral head. Early diagnosis and treatment","volume":"67","author":"Ficat","year":"1985","journal-title":"J Bone Joint Surg Br"},{"key":"10.1016\/j.jbspin.2011.04.013_bib0020","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1302\/0301-620X.77B1.7822393","article-title":"A quantitative system for staging avascular necrosis","volume":"77","author":"Steinberg","year":"1995","journal-title":"J Bone Joint Surg Br"},{"key":"10.1016\/j.jbspin.2011.04.013_bib0025","doi-asserted-by":"crossref","unstructured":"Hernigou P, Beaujean F. Treatment of osteonecrosis with autologous bone marrow grafting. Clin Orthop Relat Res 2002;405:14\u201323.","DOI":"10.1097\/00003086-200212000-00003"},{"key":"10.1016\/j.jbspin.2011.04.013_bib0030","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2106\/00004623-200406000-00006","article-title":"Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells. A pilot study","volume":"86-A","author":"Gangji","year":"2004","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.jbspin.2011.04.013_bib0035","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1038\/leu.2008.217","article-title":"Secretion of angiogenic proteins by human multipotent mesenchymal stromal cells and their clinical potential in the treatment of avascular osteonecrosis","volume":"22","author":"M\u00fcller","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.jbspin.2011.04.013_bib0040","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.jbspin.2009.04.002","article-title":"The effect of bone marrow mononuclear cells on vascularization and bone regeneration in steroid-induced osteonecrosis of the femoral head","volume":"76","author":"Sun","year":"2009","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2011.04.013_bib0045","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jbspin.2010.01.002","article-title":"Mesenchymal stem cells: a new biotherapy for bone disease?","volume":"77","author":"Lafforgue","year":"2010","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2011.04.013_bib0050","doi-asserted-by":"crossref","unstructured":"Mont MA, Etienne G, Ragland PS. Outcome of nonvascularized bone grafting for osteonecrosis of the femoral head. Clin Orthop Relat Res 2003;417:84\u201392.","DOI":"10.1097\/01.blo.0000096826.67494.38"},{"key":"10.1016\/j.jbspin.2011.04.013_bib0055","doi-asserted-by":"crossref","unstructured":"Cui Q, Botchwey EA. Emerging ideas: treatment of precollapse osteonecrosis using stem cells and growth factors. Clin Orthop Relat Res 2010; doi:10.1007\/s11999-010-1738-1.","DOI":"10.1007\/s11999-010-1738-1"},{"key":"10.1016\/j.jbspin.2011.04.013_bib0060","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.2106\/JBJS.D.02959","article-title":"The use of alendronate to prevent early collapse of the femoral head in patients with non traumatic osteonecrosis. A randomized clinical study","volume":"87","author":"Lai","year":"2005","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.jbspin.2011.04.013_bib0065","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1302\/0301-620X.91B8.21518","article-title":"The use of alendronate in the treatment of avascular necrosis of the femoral head: follow-up to 8\u00a0years","volume":"91","author":"Agarwala","year":"2009","journal-title":"J Bone Joint Surg Br"},{"key":"10.1016\/j.jbspin.2011.04.013_bib0070","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.bone.2009.04.255","article-title":"Systemic effects of zoledronic acid in children with traumatic femoral head avascular necrosis and Legg-Calve-Perthes disease","volume":"45","author":"Johannesen","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.jbspin.2011.04.013_bib0075","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","article-title":"IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines","volume":"23","author":"Schmitz","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.jbspin.2011.04.013_bib0080","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.it.2009.03.003","article-title":"Interleukin-33 \u2013 cytokine of dual function or novel alarmin?","volume":"30","author":"Haraldsen","year":"2009","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jbspin.2011.04.013_bib0085","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1073\/pnas.0606854104","article-title":"IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo","volume":"104","author":"Carriere","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jbspin.2011.04.013_bib0090","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.immuni.2009.05.007","article-title":"Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases","volume":"31","author":"L\u00fcthi","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.jbspin.2011.04.013_bib0095","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.bbrc.2009.12.107","article-title":"Caspase\u00a03 inactivates biologically active full length interleukin-33 as a classical cytokine but does not prohibit nuclear translocation","volume":"391","author":"Ali","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jbspin.2011.04.013_bib0100","doi-asserted-by":"crossref","first-page":"7890","DOI":"10.4049\/jimmunol.0802449","article-title":"Caspase-1, caspase-8, and calpain are dispensable for IL-33 release by macrophages","volume":"183","author":"Ohno","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.jbspin.2011.04.013_bib0105","doi-asserted-by":"crossref","first-page":"9021","DOI":"10.1073\/pnas.0812690106","article-title":"The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1","volume":"106","author":"Cayrol","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jbspin.2011.04.013_bib0110","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1365-2567.2009.03221.x","article-title":"Expression and regulation of interleukin-33 in human monocytes","volume":"130","author":"Nile","year":"2010","journal-title":"Immunology"},{"key":"10.1016\/j.jbspin.2011.04.013_bib0115","doi-asserted-by":"crossref","first-page":"e3331","DOI":"10.1371\/journal.pone.0003331","article-title":"The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel \u201calarmin\u201d?","volume":"3","author":"Moussion","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.jbspin.2011.04.013_bib0120","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.cyto.2010.11.021","article-title":"IL-33 is expressed in human osteoblasts, but has no direct effect on bone remodeling","volume":"53","author":"Saidi","year":"2010","journal-title":"Cytokine"},{"key":"10.1016\/j.jbspin.2011.04.013_bib0125","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/jbmr.269","article-title":"Interleukin-33 is expressed in differentiated osteoblasts and blocks osteoclast formation from bone marrow precursor cells","volume":"26","author":"Schulze","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2011.04.013_bib0130","doi-asserted-by":"crossref","unstructured":"Saleh H, Eeles D, Hodge JM, et al. Interleukin-33, a target of parathyroid hormone and oncostatin m, increases osteoblastic matrix mineral deposition and inhibits osteoclast formation in vitro. Endocrinology 2011;152:1911\u201322.","DOI":"10.1210\/en.2010-1268"},{"key":"10.1016\/j.jbspin.2011.04.013_bib0135","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbrc.2009.04.081","article-title":"IL-33, a recently identified interleukin-1 gene family member, is expressed in human adipocytes","volume":"384","author":"Wood","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jbspin.2011.04.013_bib0140","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/art.24305","article-title":"Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis","volume":"60","author":"Palmer","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2011.04.013_bib0145","doi-asserted-by":"crossref","first-page":"18660","DOI":"10.1073\/pnas.0705939104","article-title":"IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells","volume":"104","author":"Ali","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jbspin.2011.04.013_bib0150","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.4049\/jimmunol.179.4.2551","article-title":"IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex","volume":"179","author":"Chackerian","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.jbspin.2011.04.013_bib0155","doi-asserted-by":"crossref","first-page":"26369","DOI":"10.1074\/jbc.M704916200","article-title":"Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation","volume":"282","author":"Hayakawa","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jbspin.2011.04.013_bib0160","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1007\/s00018-010-0410-y","article-title":"Interleukin-33 stimulates formation of functional osteoclasts from human CD14(+) monocytes","volume":"67","author":"Mun","year":"2010","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jbspin.2011.04.013_bib0165","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1471-2172-11-52","article-title":"Interleukin-33 contributes to both M1 and M2 chemokine marker expression in human macrophages","volume":"11","author":"Joshi","year":"2010","journal-title":"BMC Immunol"},{"key":"10.1016\/j.jbspin.2011.04.013_bib0170","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1172\/JCI200523394","article-title":"IL-1 mediates TNF-induced osteoclastogenesis","volume":"115","author":"Wei","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jbspin.2011.04.013_bib0175","doi-asserted-by":"crossref","first-page":"5926","DOI":"10.4049\/jimmunol.1001591","article-title":"Direct inhibition of human RANK+ osteoclast precursors identifies a homeostatic function of IL-1beta","volume":"185","author":"Lee","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.jbspin.2011.04.013_bib0180","unstructured":"Tsai CL, Liu TK. Evidence for eicosanoids within the reparative front in a vascular necrosis of human femoral head. Clin Orthop Relat Res 1992;281:305\u201312."},{"key":"10.1016\/j.jbspin.2011.04.013_bib0185","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1752-8062.2009.00133.x","article-title":"Synovial inflammation in patients with osteonecrosis of the femoral head","volume":"2","author":"Rabquer","year":"2009","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.jbspin.2011.04.013_bib0190","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1002\/eji.200737547","article-title":"IL-33 is a chemoattractant for human Th2 cells","volume":"37","author":"Komai-Koma","year":"2007","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jbspin.2011.04.013_bib0195","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/intimm\/dxn060","article-title":"IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells","volume":"20","author":"Smithgall","year":"2008","journal-title":"Int Immunol"},{"key":"10.1016\/j.jbspin.2011.04.013_bib0200","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.cyto.2007.09.013","article-title":"Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells","volume":"40","author":"Moulin","year":"2007","journal-title":"Cytokine"},{"key":"10.1016\/j.jbspin.2011.04.013_bib0205","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1182\/blood-2008-05-157818","article-title":"Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33","volume":"113","author":"Pecaric-Petkovic","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jbspin.2011.04.013_bib0210","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1002\/eji.200939472","article-title":"IL-33 promotes DC development in BM culture by triggering GM-CSF production","volume":"39","author":"Mayuzumi","year":"2009","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jbspin.2011.04.013_bib0215","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1073\/pnas.0712116105","article-title":"IL-33 mediates antigen-induced cutaneous and articular hypernociception in mice","volume":"105","author":"Verri","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jbspin.2011.04.013_bib0220","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nri2062","article-title":"Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems","volume":"7","author":"Takayanagi","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jbspin.2011.04.013_bib0225","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1146\/annurev.immunol.24.021605.090646","article-title":"Osteoimmunology: interplay between the immune system and bone metabolism","volume":"24","author":"Walsh","year":"2006","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jbspin.2011.04.013_bib0230","doi-asserted-by":"crossref","first-page":"9656","DOI":"10.1073\/pnas.152324099","article-title":"Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover","volume":"99","author":"Street","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jbspin.2011.04.013_bib0235","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1002\/art.24847","article-title":"Continuous occurrence of both insufficient neovascularization and elevated vascular permeability in rabbit proximal femur during inadequate repair of steroid-associated osteonecrotic lesions","volume":"60","author":"Zhang","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2011.04.013_bib0240","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/micr.10190","article-title":"VEGF-promoted surgical angiogenesis in necrotic bone","volume":"24","author":"Suzuki","year":"2004","journal-title":"Microsurgery"},{"key":"10.1016\/j.jbspin.2011.04.013_bib0245","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.orthres.2004.08.013","article-title":"Vascular endothelial growth factor (VEGF) gene transfer enhances surgical revascularization of necrotic bone","volume":"23","author":"Katsube","year":"2005","journal-title":"J Orthop Res"},{"key":"10.1016\/j.jbspin.2011.04.013_bib0250","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1182\/blood-2009-02-203372","article-title":"Interleukin-33 induces angiogenesis and vascular permeability through ST2\/TRAF6-mediated endothelial nitric oxide production","volume":"114","author":"Choi","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jbspin.2011.04.013_bib0255","doi-asserted-by":"crossref","first-page":"4705","DOI":"10.4049\/jimmunol.0901511","article-title":"The role of macrophage-derived IL-1 in induction and maintenance of angiogenesis","volume":"183","author":"Carmi","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.jbspin.2011.04.013_bib0260","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1096\/fj.02-0134fje","article-title":"Interleukin-1alpha promotes angiogenesis in vivo via VEGFR-2 pathway by inducing inflammatory cell VEGF synthesis and secretion","volume":"16","author":"Salven","year":"2002","journal-title":"FASEB J"},{"key":"10.1016\/j.jbspin.2011.04.013_bib0265","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1354\/vp.40-4-345","article-title":"Osteonecrosis of the femoral head of laboratory animals: the lessons learned from a comparative study of osteonecrosis in man and experimental animals","volume":"40","author":"Boss","year":"2003","journal-title":"Vet Pathol"},{"key":"10.1016\/j.jbspin.2011.04.013_bib0270","doi-asserted-by":"crossref","first-page":"250","DOI":"10.4055\/cios.2010.2.4.250","article-title":"Apoptosis in the osteonecrosis of the femoral head","volume":"2","author":"Youm","year":"2010","journal-title":"Clin Orthop Surg"},{"key":"10.1016\/j.jbspin.2011.04.013_bib0275","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1210\/jc.85.8.2907","article-title":"Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis of the hip","volume":"85","author":"Weinstein","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2011.04.013_bib0280","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1084\/jem.20071868","article-title":"IL-33 reduces the development of atherosclerosis","volume":"205","author":"Miller","year":"2008","journal-title":"J Exp Med"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X11001163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X11001163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T20:44:20Z","timestamp":1686170660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X11001163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":56,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S1297319X11001163"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2011.04.013","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}